SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000882796-05-000043
Filing Date
2005-12-20
Accepted
2005-12-20 11:18:32
Documents
2
Period of Report
2005-12-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 3  
1 PRIMARY DOCUMENT doc.xml 3 1537
2 POWER OF ATTORNEY LETTER powerofattorney.txt EX-24 2604
  Complete submission text file 0000882796-05-000043.txt   5922
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address AMGEN INC ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799
SEIDENBERG BETH C (Reporting) CIK: 0001184592 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-23186 | Film No.: 051274509